Codexis Prices 16.7 Million Share Offering to Fund Enzymatic Oligonucleotide Manufacturing Growth
Codexis priced an underwritten public offering of 16,666,667 shares of common stock to raise capital for oligonucleotide therapeutic manufacturing
Read the full story on market.news
🇬🇧 United Kingdom Stocks IPO biotech pharma ipo healthcare
What is your take? Drop your thoughts below. 